It’s not hyperbole to say that people will die.” PEPFAR, a sprawling multiagency public health program led by the State Department, disburses billions of dollars in aid to partners around the world to fight HIV every year.

Phillip Faithfull, now 66, contracted HIV in the mid-1980s but did not begin treatment until 2007, when he became ill with pneumonia. Retired barman Phillip was admitted to the "kind and compassionate" 10-bed inpatient unit run by the Sussex Beacon in Brighton.

Is there an HIV epidemic? There are several factors making the issue of HIV and AIDs among Black folks very concerning.

On Friday, a memorandum signed by Marco Rubio called for a 90-day cessation of foreign aid. That would likely put on hold the work of PEPFAR, the President's Emergency Plan for AIDS Relief.

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how to design a vaccine

A meta-analysis found a low risk of HIV transmission in people taking antiretroviral therapy (ART) in high-income countries.

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes already bound to the virus — knowledge that could lead to better vaccines.

Researchers at the University of Massachusetts Amherst have quantified the impacts of a constellation of social factors on the spread of HIV. Their study, published in Health Care Management Science,

Advocates for people with HIV are concerned the Biden administration will not fully implement a ruling that allows enlistment by healthy HIV-positive Americans, leaving the matter to Trump.

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection.

The HIV epidemic continues to disproportionately affect major urban centers across the United States, with southern cities facing particularly severe

This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who weigh at least 13 pounds.